Palisade Bio, Inc. Common Stock

PALI XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

320M

Short interest (May 15)

15.5%

Net Short (Jun 03 ): 0.0%

Borrow Fee

1.00%

↑ 20.8%

Available Shares

10M

↓ 0.0%

Price Chart

Company Overview

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001357459

Asset Type: CS

Market Data

Market Cap: $323,230,186

Employees: 14

Status: Active

Short Interest

Current Borrow Fee 1.00%

Range: 0.42% - 1.00%

Available Shares 10M

Range: 10M - 10M

Recent Changes

Fee Change: ↑ 68.8%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime